Published in Gastroenterology on September 01, 1968
Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest (1973) 5.31
The gastric mucosal barrier: clinical and experimental studies in critically ill and normal man, and in the rabbit. Ann Surg (1970) 1.14
Peptic ulcer: a reappraisal of its aetiology. Ann R Coll Surg Engl (1972) 1.01
The pathophysiology of peptic ulcer disease. Dig Dis Sci (1985) 0.96
Effect of intragastric bile salts on ionic movement across normal human gastric mucosa after intravenous atropine. Gut (1971) 0.96
Acute haemorrhagic gastritis: modern concepts based on pathogenesis. Gut (1971) 0.89
Divergent nature of gastric mucosal permeability and gastric acid secretion in sick patients with general surgical and neurosurgical disease. Ann Surg (1973) 0.86
Effect of cimetidine on ion fluxes and potential difference across the human stomach. Gut (1978) 0.81
Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa. Gut (1998) 0.80
Oesophageal reflux and gastric secretion. Gut (1970) 0.79
The effect of citric acid and its sodium salts in test meals on the gastric outputs of acid and of chloride. J Physiol (1973) 0.77
Potential difference across the normal and the abnormal gastric mucosa in man. Gut (1976) 0.76
Lithium fluxes across the gastric mucosa after truncal vagotomy and drainage--an objective assessment of mucosal injury. Gut (1986) 0.75
Studies on the pathogenesis of benign gastric ulcer: increased back diffusion of hydrogen ion in experimental atrophic gastritis. Ann Surg (1972) 0.75
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate. Cancer (1984) 1.73
Canadian experience with predictive testing for Huntington disease: lessons for genetic testing centers and policy makers. Am J Med Genet (1992) 1.59
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Perpetuation of published medical errors. Lancet (1993) 1.43
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Granulomatous ileocolitis. Gut (1966) 1.42
An accident and emergency department experience. J R Soc Med (1993) 1.39
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22
Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut (1981) 1.22
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo. Mol Cell Biol (2005) 1.16
Influence of glucagon on pancreatic exocrine secretion. Gastroenterology (1969) 1.12
Secretion of calcium by the canine pancreas. Gastroenterology (1967) 1.10
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon? Am J Gastroenterol (1974) 1.06
Mucosal blood flow in canine antral and fundic pouches. Gastroenterology (1971) 1.04
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunol Immunother (2003) 1.04
Lymphoma in inflammatory bowel disease. Cancer (1992) 1.03
Effect of secretin and acetazolamide on the volume and electrolyte composition of hepatic bile in man. Gastroenterology (1969) 1.02
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01
Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol (1987) 1.00
Quality of life after surgery for Crohn's disease: a psychosocial survey. Gastroenterology (1980) 0.99
A family with collagenous colitis, ulcerative colitis, and Crohn's disease. Am J Gastroenterol (2000) 0.98
Secretory capacity of stomach and pancreas in man. Gastroenterology (1967) 0.97
Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol (1994) 0.95
Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial. J Clin Gastroenterol (1990) 0.95
Intraabdominal abscess in Crohn's (ileo) colitis. Am J Surg (1982) 0.95
In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut (2000) 0.94
"Natural history" of Crohn's disease. An analytic review of the placebo lesson. Gastroenterology (1984) 0.94
Effects of prostaglandin E1 on pancreatic exocrine function. Gastroenterology (1971) 0.94
Cancer in universal and left-sided ulcerative colitis: clinical and pathologic features. Mt Sinai J Med (1979) 0.92
Autoimmune hemolytic anemia in ulcerative colitis: report of three cases, review of the literature, and evaluation of modes of therapy. Dig Dis Sci (1979) 0.92
Effect of glucagon on hepatic bile secretion in man. Gastroenterology (1971) 0.92
Folic acid and hexose absorption in sprue. Am J Dig Dis (1974) 0.91
How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol (1995) 0.90
The pancreas. Gastroenterology (1966) 0.90
Bile in the stomach. Gastroenterology (1969) 0.90
Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol (1980) 0.89
Some metabolic aspects of exocrine pancreatic disease. Gastroenterology (1969) 0.89
Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut (1973) 0.89
Fulminant herpes simplex hepatitis in a patient with ulcerative colitis. Gut (1988) 0.88
Rectourethroperineal fistula in Crohn's disease. Am J Gastroenterol (1985) 0.88
Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology (1988) 0.88
Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch (1997) 0.87
Carcinoma of the ileum 25 years after bypass for regional enteritis. A case report. Mt Sinai J Med (1971) 0.87
Alterations in serum immunoglobulins after resection for ulcerative and granulomatous disease of the intestine. Gut (1972) 0.87
Controversy on recurrent ileitis after ileostomy: background and speculation. Gastroenterology (1973) 0.87
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol (1993) 0.87
Toxic megacolon in ulcerative colitis complicated by pneumomediastinum: report of two cases. Gastroenterology (1980) 0.87
The effect of bile on electrolyte movement across canine gastric antral and fundic mucosa. Gastroenterology (1970) 0.86
Mycobacterium avium-intracellulare-associated colitis in a patient with the acquired immunodeficiency syndrome. J Clin Gastroenterol (1984) 0.86
Systemic amyloidosis and the gastrointestinal tract. Gastroenterol Clin North Am (1998) 0.86
Crohn's disease--50 years later. N Engl J Med (1981) 0.85
Electrolyte movement across canine antral and fundic gastric mucosa. Gastroenterology (1969) 0.85
[How to calculate the natural history of a disease]. Gastroenterol Clin Biol (1979) 0.85
Granulomatous colitis in association with diverticula. N Engl J Med (1970) 0.85
Editorial: A transmissible agent in Crohn's disease? New pursuit of an old concept. N Engl J Med (1975) 0.84
Inhibitory effect of ethanol on canine exocrine pancreatic secretion. Gastroenterology (1972) 0.84
Pentagastrin infusion-glycine instillation as a measure of acid absorption in the human stomach: comparison to an instilled acid load. Gastroenterology (1972) 0.84
Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology (1983) 0.83
Effect of acetazolamide and cholecystokinin on the secretion of pepsin from histamine-stimulated Heidenhain pouches. Gastroenterology (1967) 0.83
In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology (1991) 0.82
The effect of alloxan upon canine exocrine pancreatic secretion. Am J Gastroenterol (1968) 0.82
Effects of some inhibitors of sodium transport (adenosine triphosphatase inhibitors) on pancreatic secretion. Gastroenterology (1972) 0.81
Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Scand J Gastroenterol Suppl (1988) 0.81
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81
Mucosal diaphragm of the gastric antrum. Gastrointest Endosc (1965) 0.81
The "natural history" of ulcerative colitis: an analysis of the placebo response. J Clin Gastroenterol (1989) 0.81
Problems in Crohn's disease: evaluation of the results of surgical treatments. J Chronic Dis (1975) 0.81
Expression of sialosyl-Tn in intestinal type cancer cells of human gastric cancers. Acta Pathol Jpn (1993) 0.80